Essential Steps to Implementing Guidelines for Cognitive Dysfunction in Diabetes
Evidence to date suggests that the risk for all-cause dementia is 40% to 60% higher in patients with type 1 or type 2 diabetes.
Diabetes
Association for Diabetes, Stroke Risk Varies by Age, Race, Sex
The magnitude of the association of diabetes with stroke risk varies by age, race, and sex.
Perineural Injection of Platelet-Rich Plasma for Peripheral Neuropathy Pain
Perineural injection of platelet-rich plasma may improve pain and numbness associated with diabetic peripheral neuropathy, and enhance peripheral nerve function.
Hyperglycemia May Worsen Outcomes of Intravenous Thrombolysis in Patients With Acute Ischemic Stroke
Hyperglycemia on admission is associated with worse clinical outcomes in patients with and without diabetes following intravenous thrombolysis for acute ischemic stroke.
Diabetic Peripheral Neuropathy Associated With Increased Health Care Costs
Researchers found a substantial cohort of adults with diabetic peripheral neuropathy in the United States with high financial and social costs.
Group Acupuncture May Be Beneficial for Painful Diabetic Neuropathy
Group acupuncture may alleviate pain and improve quality of life in patients with painful diabetic neuropathy.
Late-Life Diabetes Status Tied to New Cognitive Impairment
Diabetes, poor glycemic control, and longer diabetes duration are associated with worse cognitive outcomes in older adults.
Midlife Diabetes Increases Cerebral Infarction, Arterial Occlusion Risk in Late Life
Patients with midlife type 2 diabetes have a significantly increased risk for cerebral infarction and occlusion of cerebral arteries later in life.
High Adolescent Fasting Plasma Glucose May Have an Impact on Brain Health in Midlife
Mean fasting plasma glucose in the high-normal range during early adolescence may be associated with poorer brain health in midlife.
Clinical Outcomes Compared With Generics, Brand-Name Drugs for Chronic Conditions
An analysis of data from over 3.5 million patients found comparable clinical outcomes among patients who initiated generics vs those who were treated with brand-name drugs for chronic conditions such as diabetes, hypertension, osteoporosis, depression and anxiety.
Next post in Uncategorized
